Real-World Study of Everolimus in Advanced Progressive Neuroendocrine Tumors

Everolimus is a valid therapeutic option for neuroendocrine tumors (NETs); however, data in a real-world setting outside regulatory trials are sparse. The aim of this study was to determine everolimus tolerability and efficacy, in relation to previous treatments, in a compassionate use program. A to...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Panzuto, Francesco, Rinzivillo, Maria, Fazio, Nicola, de Braud, Filippo, Luppi, Gabriele, Zatelli, Maria Chiara, Lugli, Francesca, Tomassetti, Paola, Riccardi, Ferdinando, Nuzzo, Carmen, Brizzi, Maria Pia, Faggiano, Antongiulio, Zaniboni, Alberto, Nobili, Elisabetta, Pastorelli, Davide, Cascinu, Stefano, Merlano, Marco, Chiara, Silvana, Antonuzzo, Lorenzo, Funaioli, Chiara, Spada, Francesca, Pusceddu, Sara, Fontana, Annalisa, Ambrosio, Maria Rosaria, Cassano, Alessandra, Campana, Davide, Cartenì, Giacomo, Appetecchia, Marialuisa, Berruti, Alfredo, Colao, Annamaria, Falconi, Massimo, Delle Fave, Gianfranco
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AlphaMed Press 2014
Konular:
Gastrointestinal Cancer
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4153458/
https://ncbi.nlm.nih.gov/pubmed/25117065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0037
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller